Audible会員プラン登録で、20万以上の対象タイトルが聴き放題。

プレビューの再生

Audible会員プラン 無料体験

会員は、20万以上の対象作品が聴き放題
アプリならオフライン再生可能
プロの声優や俳優の朗読も楽しめる
Audibleでしか聴けない本やポッドキャストも多数
無料体験終了後は月会費1,500円。いつでも退会できます

From Breakthrough to Blockbuster

著者: Donald L. Drakeman, Lisa N. Drakeman, Nektarios Oraiopoulos
ナレーター: Chris Andrew Ciulla
30日間の無料体験を試す

無料体験終了後は月額¥1,500。いつでも退会できます。

¥2,200 で購入

¥2,200 で購入

下4桁がのクレジットカードで支払う
ボタンを押すと、Audibleの利用規約およびAmazonのプライバシー規約同意したものとみなされます。支払方法および返品等についてはこちら

あらすじ・解説

Beginning in the 1970s, several scientific breakthroughs promised to transform the creation of new medicines. As investors sought to capitalize on these Nobel Prize-winning discoveries, the biotech industry grew to thousands of small companies around the world. Each sought to emulate what the major pharmaceutical companies had been doing for a century or more, but without the advantages of scale, scope, experience, and massive resources.

Biotech companies have met the challenge by creating nearly 40% more of the most important treatments for previously unmet medical needs. Moreover, they have done so with much lower overall costs.

From Breakthrough to Blockbuster focuses on both the companies themselves and the broader biotech ecosystem that supports them. It paints a portrait of the crucial roles played by academic research, venture capital, contract research organizations, the capital markets, and pharmaceutical companies, demonstrating how a supportive environment enabled the entrepreneurial biotech industry to create novel medicines with unprecedented efficiency. In doing so, it also offers insights for any industry seeking to innovate in uncertain and ambiguous conditions.

©2022 Oxford University Press (P)2022 Ascent Audio

From Breakthrough to Blockbusterに寄せられたリスナーの声

カスタマーレビュー:以下のタブを選択することで、他のサイトのレビューをご覧になれます。